Rhamnus Cathartica (Hahnemann Laboratories, Inc.)
Welcome to the PulseAid listing for the Rhamnus Cathartica drug offered from Hahnemann Laboratories, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hahnemann Laboratories, Inc. |
NON-PROPRIETARY NAME: | Rhamnus Cathartica |
SUBSTANCE NAME: | RHAMNUS CATHARTICA FRUIT |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | BUCCAL; ORAL; SUBLINGUAL |
DOSAGE FORM: | PELLET |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2017-01-18 |
END MARKETING DATE: | 0000-00-00 |
Rhamnus Cathartica HUMAN OTC DRUG Details:
Item Description | Rhamnus Cathartica from Hahnemann Laboratories, Inc. |
LABELER NAME: | Hahnemann Laboratories, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30([hp_C]/[hp_C]) |
START MARKETING DATE: | 2017-01-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63545-674_46638d75-9a7e-67ae-e054-00144ff8d46c |
PRODUCT NDC: | 63545-674 |
APPLICATION NUMBER: | |
Other RHAMNUS CATHARTICA FRUIT Pharmaceutical Manufacturers / Labelers: